14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $7.97 $10.47 Wednesday, 1st May 2024 ZYME stock ended at $8.76. This is 2.10% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 5.26% from a day low at $8.55 to a day high of $9.00.
90 days $7.97 $13.14
52 weeks $6.02 $13.14

Historical Zymeworks Inc prices

Date Open High Low Close Volume
Jan 12, 2024 $11.11 $11.18 $10.63 $10.88 223 892
Jan 11, 2024 $10.91 $11.08 $10.54 $10.97 437 089
Jan 10, 2024 $11.54 $11.68 $10.80 $10.98 491 733
Jan 09, 2024 $11.46 $11.57 $11.13 $11.50 510 349
Jan 08, 2024 $10.56 $11.63 $10.44 $11.54 751 048
Jan 05, 2024 $10.70 $10.89 $10.36 $10.56 729 612
Jan 04, 2024 $10.78 $10.96 $10.52 $10.83 482 942
Jan 03, 2024 $10.43 $10.77 $10.31 $10.67 564 461
Jan 02, 2024 $10.26 $10.67 $10.25 $10.38 355 775
Dec 29, 2023 $10.71 $10.72 $10.35 $10.39 300 983
Dec 28, 2023 $10.70 $10.92 $10.58 $10.70 269 090
Dec 27, 2023 $10.82 $10.99 $10.70 $10.75 560 982
Dec 26, 2023 $10.00 $10.83 $10.00 $10.68 793 941
Dec 22, 2023 $9.38 $9.88 $9.34 $9.83 398 986
Dec 21, 2023 $9.36 $9.53 $9.29 $9.32 266 551
Dec 20, 2023 $9.38 $9.65 $9.26 $9.27 354 667
Dec 19, 2023 $9.11 $9.36 $9.11 $9.33 358 716
Dec 18, 2023 $9.06 $9.25 $8.96 $9.06 545 200
Dec 15, 2023 $9.08 $9.33 $9.00 $9.10 1 103 179
Dec 14, 2023 $9.40 $9.41 $8.87 $9.02 423 071
Dec 13, 2023 $9.19 $9.27 $8.94 $9.25 644 836
Dec 12, 2023 $9.20 $9.41 $9.15 $9.19 336 106
Dec 11, 2023 $9.23 $9.40 $9.05 $9.22 266 279
Dec 08, 2023 $9.46 $9.53 $9.20 $9.29 323 426
Dec 07, 2023 $9.18 $9.56 $9.15 $9.55 434 782
Click to get the best stock tips daily for free!

About Zymeworks Inc

Zymeworks Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 ... ZYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT